Stagr Allergy Centers

Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of allergies through allergen immunotherapy (AIT). The company offers a comprehensive portfolio of sublingual (drops and tablets) and subcutaneous treatments designed to desensitize the immune system to specific allergens. Formed by the 2015 merger of France-based Stallergenes and US-based Greer Laboratories, it operates across the entire value chain, from allergen production to clinical development and commercialization. Its flagship products include Oralair and Actair for respiratory allergies caused by grass pollen and house dust mites. Headquartered in London, the company serves patients in over 40 countries and is currently a private entity owned by Waypoint Capital.